0001062993-22-008797.txt : 20220328
0001062993-22-008797.hdr.sgml : 20220328
20220328193810
ACCESSION NUMBER: 0001062993-22-008797
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220328
FILED AS OF DATE: 20220328
DATE AS OF CHANGE: 20220328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DRISCOLL FREDERICK W
CENTRAL INDEX KEY: 0001129890
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39271
FILM NUMBER: 22776991
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Renovacor, Inc.
CENTRAL INDEX KEY: 0001799850
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: P.O. BOX 8142
CITY: GREENWICH
STATE: CT
ZIP: 06836
BUSINESS PHONE: 610-424-2650
MAIL ADDRESS:
STREET 1: P.O. BOX 8142
CITY: GREENWICH
STATE: CT
ZIP: 06836
FORMER COMPANY:
FORMER CONFORMED NAME: Chardan Healthcare Acquisition 2 Corp.
DATE OF NAME CHANGE: 20200306
FORMER COMPANY:
FORMER CONFORMED NAME: Chardan Healthcare Acquisition III Corp.
DATE OF NAME CHANGE: 20200113
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-03-28
0001799850
Renovacor, Inc.
RCOR
0001129890
DRISCOLL FREDERICK W
RENOVACOR, INC.
P.O. BOX 8142
GREENWICH
CT
06836
0
1
0
0
Chief Financial Officer
Option
4.30
2022-03-28
4
A
0
155325
0
A
2032-03-28
Common Stock
155325
155325
D
The stock option will vest and become exercisable in full on March 28, 2026, with 25% vesting on March 28, 2023, and the remainder vesting in equal monthly installments for the remaining 36 months, subject to the continuous service of the Reporting Person on such vesting date.
/s/ Joseph Carroll, as attorney-in-fact
2022-03-28